PWP
MRNA icon

Principle Wealth Partners’s Moderna MRNA Stock Holding History

Principle Wealth Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,501
Closed -$297K – 346
2024
Q2 		$297K Buy
2,501
+4
+0.2% +$506 0.02% 278
2024
Q1 		$266K Buy
2,497
+102
+4% +$10.3K 0.02% 299
2023
Q4 		$238K Sell
2,395
-100
-4% -$8.41K 0.02% 303
2023
Q3 		$258K Hold
2,495
– – 0.03% 274
2023
Q2 		$303K Sell
2,495
-250
-9% -$33.4K 0.03% 261
2023
Q1 		$422K Hold
2,745
– – 0.05% 212
2022
Q4 		$493K Hold
2,745
– – 0.06% 193
2022
Q3 		$325 Hold
2,745
– – 0.03% 225
2022
Q2 		$392K Buy
2,745
+8
+0.3% +$1.14K 0.05% 215
2022
Q1 		$471K Hold
2,737
– – 0.05% 210
2021
Q4 		$695K Sell
2,737
-248
-8% -$72.5K 0.07% 172
2021
Q3 		$1.15M Sell
2,985
-650
-18% -$240K 0.13% 120
2021
Q2 		$854K Buy
3,635
+300
+9% +$53.6K 0.1% 144
2021
Q1 		$437K Hold
3,335
– – 0.05% 204
2020
Q4 		$348K Buy
3,335
+135
+4% +$13.7K 0.05% 210
2020
Q3 		$226K Buy
3,200
+2,200
+220% +$153K 0.06% 138
2020
Q2 		$64K Buy
+1,000
New +$54.8K 0.02% 255

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principle Wealth Partners's MRNA Position: Q3 2024 in Review

Principle Wealth Partners sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,501 shares — an estimated $297K sold.

Principle Wealth Partners first reported a position in MRNA in Q2 2020 and held it in 17 quarters. The position peaked at $1.15M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Principle Wealth Partners reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Principle Wealth Partners sold 2,501 Moderna shares in Q3 2024, an estimated $297K.
  • Principle Wealth Partners first reported a position in Moderna in Q2 2020 and held it in 17 quarters.
  • Principle Wealth Partners's Moderna position peaked at $1.15M in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Principle Wealth Partners's 13F filing for Q3 2024, filed 13 Nov 2024.